Abstract
BackgroundMajor infections are one of the leading causes of morbidity and mortality in patients with systemic lupus erythematosus (SLE), and one of key concerns when considering the risk of immunosuppressive...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
